Oct 24, 2024
Zynex Reports Third Quarter 2024 Financial Results
Oct 16, 2024
Zynex Sets Third Quarter 2024 Earnings Call
Sep 04, 2024
Zynex to Present at the HC Wainwright Global Investment Conference
Sep 03, 2024
Zynex Obtains FDA clearance for new Pain Management Device
Jun 10, 2024
Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024
May 09, 2024
Zynex to Present at the RBC Capital Markets Global Healthcare Conference
May 07, 2024
Zynex Executives Recognized Among Top 25 in Medical Technology
Feb 29, 2024
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 20, 2024
Zynex Introduces New Products
Feb 06, 2024
Zynex Receives FDA Clearance for its Next Generation NMES Device
Feb 02, 2024
Zynex Recognized in Top 25 Medical Device Companies for 2024
Feb 18, 2021
Zynex Schedules 2020 Fourth Quarter and Full-Year Earnings Call
Jan 28, 2021
Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical
Jan 12, 2021
Zynex Announces 117% Year over Year Order Growth and Increases Adjusted EBITDA Estimate
Nov 17, 2020
Zynex to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
Oct 20, 2020
Zynex Schedules 2020 Third Quarter Earnings
Oct 12, 2020
Zynex Announces 96% Year over Year Order Growth
Oct 06, 2020
Zynex Continued Growth Leads to a New Manufacturing and Warehouse Facility
Sep 03, 2020
Zynex Reports 83% Order Growth for July and August
Jul 28, 2020
Zynex Announces Second Quarter 2020 Earnings